NCCN Recommends Zanubrutinib as First-Line, Second-Line Therapy in CLL/SLL
CURE® Educated Patient® Leukemia & Lymphoma Summit on October 24, 2020, 10 AM ET – 4 PM ET
This virtual event is seeking to educate, inform and challenge the thinking of patients with any stage of leukemia or lymphoma, as well as patients, caregivers and advocates. Gain the opportunity to learn from expert physicians and network online with other leukemia and lymphoma patients and survivors.
The chairs for this program are Dr. Martha Arellano (Emory, Winship Cancer Institute), Dr. Jorge Cortes (Georgia Cancer Center), and Jonathon Cohen (Emory, Winship Cancer Institute). The agenda features various presentations and panel discussions on specific types of leukemia, lymphoma, treatment, and what’s on the horizon.
Related posts
